April 18, 2018 Ivanka Thompson .
Zacks has also given Pharma Mar an industry rank of 119 out of 265 based on the ratings given to its competitors.
ZACKS: PHARMA MAR (PHMMF) RECEIVED CONSENSUS RATING OF “STRONG PURCHASE” FROM ANALYSTS .
Shares of Pharma Mar (NASDAQ:PHMMF) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Separately, Zacks Investment Research upgraded shares of Pharma Mar from a “sell” rating to a “hold” rating in a report on Tuesday, March 21st.
Pharma Mar (NASDAQ:PHMMF) traded up 4.65% during midday trading on Thursday, hitting $3.15. 5,750 shares of the company were exchanged. The stock has a 50 day moving average of $3.06 and a 200-day moving average of $2.95. Pharma Mar has a 1-year low of $2.13 and a 1-year high of $3.65. The stock’s market capitalization is $696.13 million.